AsymBio, the biologics-focused Contract Development and Manufacturing Organization (CDMO) under the Asymchem Group (stock codes: 002821.SZ / 6821.HK), has announced the groundbreaking of a new research and development facility at …
CordenPharma has announced plans to acquire AmbioPharm, a move aimed at strengthening its peptide active pharmaceutical ingredient (API) manufacturing capabilities and expanding its global production network. The acquisition will enhance …
